Upregulation of miR-223-3p in diabetic cardiomyopathy modulates disease progression via the GRK2/NLRP3 signaling pathway. Yang S, Tang S, Xie D, Xu D, et al. Biochem Biophys Res Commun 2025;778:152338.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang S, Tang S, Xie D, Xu D, et al. Upregulation of miR-223-3p in diabetic cardiomyopathy modulates disease progression via the GRK2/NLRP3 signaling pathway. Biochem Biophys Res Commun 2025;778:152338.
PMID: 40743991